Exact Mass: 310.05829400000005
Exact Mass Matches: 310.05829400000005
Found 61 metabolites which its exact mass value is equals to given mass value 310.05829400000005,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Filiforminol
C15H19BrO2 (310.05683339999996)
A tricyclic sesquiterpenoid that is isolated from the Australian marine alga Laurencia filiformis.
Mefluidide
C11H13F3N2O3S (310.0598944000001)
4-Hydroxy-estazolam
4-Hydroxy-estazolam is a metabolite of estazolam. Estazolam (marketed under the brand names ProSom, Eurodin) is a benzodiazepine derivative drug developed by Upjohn in the 1970s. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. Estazolam is an intermediate-acting oral benzodiazepine. It is commonly prescribed for short-term treatment of insomnia. (Wikipedia)
Dihydroresveratrol 3-sulfate
C14H14O6S (310.05110640000004)
Dihydroresveratrol 4'-sulfate
C14H14O6S (310.05110640000004)
1-Oxoestazolam
Aplysinol
C15H19BrO2 (310.05683339999996)
10-Bromo-3-laurene-7,12-diol
C15H19BrO2 (310.05683339999996)
2-[(4-Chlorophenyl)sulfonyl]-3-piperidinoacrylonitrile
2-CHLORO-1-(4-TRIFLUOROMETHYL-BENZYL)-1H-BENZOIMIDAZOLE
N-(4-Nitrophenyl)-3-(trifluoromethyl)benzamide
C14H9F3N2O3 (310.05652399999997)
3-Bromo-4-(4-ethylcyclohexyl)benzoic acid
C15H19BrO2 (310.05683339999996)
Ethyl 6-chloro-4-hydroxy-5,8-dimethoxy-2-naphthoate
Ethyl 7-chloro-4-hydroxy-5,8-dimethoxy-2-naphthoate
(3,5-bis(trifluoromethyl)phenylethynyl)&
C13H12F6Si (310.06124239999997)
Methyl (3S)-4-bromo-3-{[dimethyl(2-methyl-2-propanyl)silyl]oxy}bu tanoate
2-[2-(5-Nitro-furan-2-yl)-vinyl]-quinoline-4-carboxylic acid
5-Amino-2-chloro-N-(2,4-dimethylphenyl)-benzenesulfonamide
azane,(3,4,5,6-tetrahydroxythian-2-yl)methyl dihydrogen phosphate
C6H19N2O8PS (310.05997040000005)
Ethyl 2-morpholin-4-yl-4-(trifluoromethyl)-1,3-thiazole-5-carboxylate
C11H13F3N2O3S (310.0598944000001)
Ethyl 7-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylate
2,6-dichloro-N-(1-cyanocycloheptyl)benzamide
C15H16Cl2N2O (310.06396259999997)
1H-Pyrrolo[2,3-b]pyridine, 5-bromo-1-[(1,1-dimethylethyl)dimethylsilyl]-
C13H19BrN2Si (310.05007939999996)
METHYL 4-(TRIFLUOROMETHYL)-6-(FURAN-2-YL)-1H-PYRROLO[2,3-B]PYRIDINE-2-CARBOXYLATE
C14H9F3N2O3 (310.05652399999997)
ethyl 4-(2-bromoethyl)-5,6,7,8-tetrahydronaphthalene-2-carboxylate
C15H19BrO2 (310.05683339999996)
dibutyl-chloro-prop-2-enylstannane
C11H23ClSn (310.05101779999995)
1H-Inden-1-one,2,3-dihydro-2-[(5-pyrazinyl-1,3,4-oxadiazol-2-yl)thio]-(9CI)
C15H10N4O2S (310.05244400000004)
7-(4-methoxyphenyl)-4-oxo-2-sulfanylidene-1H-pyrido[2,3-d]pyrimidine-5-carbonitrile
C15H10N4O2S (310.05244400000004)
(chlorosulfanyl-diphenyl-methyl)benzene
C19H15ClS (310.05829400000005)
Sodium 2-hydroxy-6,7-dimethoxy-1,2,3,4-tetrahydro-naphthalene-2-sulfonate
C12H15NaO6S (310.04870100000005)
1-[[4-(TRIFLUOROMETHOXY)PHENYL]SULFONYL]PIPERAZINE
C11H13F3N2O3S (310.0598944000001)
8-Chloro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-ol
5-(4-Morpholinylsulfonyl)-1H-indole-3-carboxylic acid
C13H14N2O5S (310.06233940000004)
4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}aniline
C14H19BrN2O (310.06806639999996)
dihydroresveratrol-3-O-sulfate
C14H14O6S (310.05110640000004)
An organic sulfate that consists of dihydroresveratrol substituted by a sulfate group at position 3. It is a metabolite of dihydroresveratrol.
O2-[3-(trifluoromethyl)benzoyl]pyrazine-2-carbohydroximamide
(4Z)-4-(4-hydroxybenzylidene)-3-(3-nitrophenyl)isoxazol-5(4H)-one
1-(5-Tert-butyl-1,3,4-thiadiazol-2-yl)-3-(4-chlorophenyl)urea
C13H15ClN4OS (310.06550500000003)
7-(4-Quinazolinyloxymethyl)-5-thiazolo[3,2-a]pyrimidinone
C15H10N4O2S (310.05244400000004)
9-chloro-3-(pyridin-4-ylmethyl)-5H-pyrimido[5,4-b]indol-4-one
12-Bromo-15-hydroxybicyclo(8.3.2)pentadeca-1(13),10(15),11-trien-14-one
C15H19BrO2 (310.05683339999996)
VAS 3947
C14H10N6OS (310.06367700000004)
VAS 3947, a specific NADPH oxidase (NOX) inhibitor, exerts a potent antiplatelet effect. VAS3947 induces apoptosis independently of anti-NOX activity, via UPR activation, mainly due to aggregation and misfolding of proteins[1][2].
{4-bromo-1,5,12-trimethyl-8-oxatricyclo[7.2.1.0²,⁷]dodeca-2(7),3,5-trien-9-yl}methanol
C15H19BrO2 (310.05683339999996)
[(1r,9s,12r)-4-bromo-1,5,12-trimethyl-8-oxatricyclo[7.2.1.0²,⁷]dodeca-2(7),3,5-trien-9-yl]methanol
C15H19BrO2 (310.05683339999996)
2-chloro-9-(4-methoxy-6-oxo-2,3-dihydropyran-2-yl)nona-2,4,6,8-tetraenoic acid
5-hydroxy-3-(4-hydroxy-3-nitrophenyl)-4-phenylpyrrol-2-one
(2z)-3-hydroxy-1-(4-methoxy-1-benzothiophen-5-yl)-3-phenylprop-2-en-1-one
(2z,4e,6e,8e)-2-chloro-9-[(2s)-4-methoxy-6-oxo-2,3-dihydropyran-2-yl]nona-2,4,6,8-tetraenoic acid
[(1r,9s,12s)-4-bromo-1,5,12-trimethyl-8-oxatricyclo[7.2.1.0²,⁷]dodeca-2(7),3,5-trien-9-yl]methanol
C15H19BrO2 (310.05683339999996)
[(1s,9r,12s)-4-bromo-1,5,12-trimethyl-8-oxatricyclo[7.2.1.0²,⁷]dodeca-2(7),3,5-trien-9-yl]methanol
C15H19BrO2 (310.05683339999996)
(1r,3r,5s,7r)-9-bromo-10,10-dimethyl-11-methylidene-3-(prop-1-en-2-yl)-4,6-dioxatricyclo[5.3.1.0¹,⁵]undec-8-ene
C15H19BrO2 (310.05683339999996)